Pharmaceutical Company Buys Out Another 20 Generic Drugs, Decides to Raise Drug Prices to…...
DAYTON, OH - CEO of Turing Pharmaceuticals Martin Shkreli made another bold announcement today that his pharmaceutical company has now bought rights for 20 more...
New Drug Company “Big Pharma” releases full range of Placebos
Despite being one of the most studied medications there has never been a range of placebos released onto the market. The newly launched Pharmaceutical...
Ten Spectacular Off-Label Uses of the Speculum
You’re probably familiar with the traditional use of the speculum: visualization of the cervical os, blah blah blah. We at Gomerblog are pleased to...
Hospital Renamed “Our Lady of Perpetual Shortage”
In honor of recent supply chain deficiencies, FDA recalls, as well as loss of manufacturing capabilities from recent environmental disasters in Puerto Rico and...
African Child Tragically Unaware He Has ‘Marker Negative Mixed Connective Tissue Disorder’
MAUN, BOTSWANA - A desperately impoverished 6-year-old boy in Sub-Saharan Africa lacks the access to medical care which could properly diagnose his "Marker Negative...
Homeopathic Drug Rep No More Effective Than Placebo, New Study Finds
A new study published by the University of South Pennington shows that Homeopathic drug reps are no more effective at convincing homeopaths to use...
FDA Approves Afternoon-After Pill
INTERCOURSE, PA - “Let’s face it: no one is getting up in the morning after an accident,” said a representative from the Food and Drug Administration...
Patient Holding $1000 new iPhone X Very Upset About $5 Prescription CoPay
LA JOLLA, CA – Natalia Miller could not understand what the idiots at the La Jolla Primary Care Clinic and Botox Salon didn’t get...
Pharmacy Creates Express Line for Psychotropic Drugs
HOUSTON, TX - A local pharmacy has taken a novel approach to meet the need of patients’ hectic schedules. Whereas most pharmacies disperse medication on...
Cancer Drug Delayed 2 Years Due to Licensing Deal
Boston, MA – Astra-Nomical has delayed their wonder cancer drug, Fizamax (ferazepatab), again. This time up to 2 years because of promotional disputes.
“We were...